abstract |
(57) SUMMARY The present invention encompasses a novel class of compounds represented by Formula I, which are caspase-3 inhibitors. The present invention further includes certain pharmaceutical compositions for the treatment of caspase-3 mediated diseases, comprising compounds of formula I. |